Mesa Operating Income from 2010 to 2024

MLAB Stock

USD 100.86 2.27 2.30%

Mesa Laboratories' Operating Income is decreasing over the years with slightly volatile fluctuation. Overall, Operating Income is projected to go to about -258.5 M this year. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Mesa Laboratories generates from its operations. View All Fundamentals

Operating Income

First Reported

1987-06-30

Previous Quarter

5.6 M

Current Value

3.5 M

Quarterly Volatility

2.1 M

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Mesa Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mesa Laboratories' main balance sheet or income statement drivers, such as Interest Expense of 6 M, Total Revenue of 227 M or Gross Profit of 139.9 M, as well as many indicators such as Price To Sales Ratio of 2.94, Dividend Yield of 0.0054 or PTB Ratio of 2.35. Mesa financial statements analysis is a perfect complement when working with Mesa Laboratories Valuation or Volatility modules.

Check out the analysis of Mesa Laboratories Correlation against competitors.

For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.

Latest Mesa Laboratories' Operating Income Growth Pattern

Below is the plot of the Operating Income of Mesa Laboratories over the last few years. Operating Income is the amount of profit realized from Mesa Laboratories operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Mesa Laboratories is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Mesa Laboratories' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mesa Laboratories' overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Mesa Operating Income Regression Statistics

	Arithmetic Mean	(32,912,550)
	Geometric Mean	12,199,305
	Coefficient Of Variation	(289.76)
	Mean Deviation	61,962,820
	Median	2,183,000
	Standard Deviation	95,368,452
	Sample Variance	9095.1T
	Range	288.4M
	R-Value	(0.67)
	Mean Square Error	5450.8T
	R-Squared	0.44
	Significance	0.01
	Slope	(14,201,538)
	Total Sum of Squares	127332T

Mesa Operating Income History

	2024	-258.5 M
	2023	-272.1 M
	2022	-30.5 M
	2021	-20.4 M
	2020	-5.3 M
	2019	-4.9 M
	2018	9.8 M

Other Fundumenentals of Mesa Laboratories

Non Operating Income Net Other

Mesa Laboratories Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Accounts Payable	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Current Deferred Revenue	Long Term Debt	Net Tangible Assets	Deferred Long Term Liab	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.9	0.48	-0.14	0.91	0.93	0.81	0.92	-0.1	0.75	0.93	0.76	0.97	0.87	0.92	0.72	0.76	0.91	0.27	-0.6	0.98	0.71	0.94
Total Stockholder Equity	0.9		0.13	0.26	0.67	0.67	0.81	0.72	0.03	0.6	0.72	0.53	0.84	0.6	0.66	0.73	0.52	0.65	-0.09	-0.52	0.89	0.72	0.77
Net Debt	0.48	0.13		-0.61	0.77	0.73	-0.01	0.71	-0.42	0.49	0.59	0.67	0.64	0.76	0.72	0.2	0.68	0.7	0.65	-0.36	0.42	-0.13	0.54
Retained Earnings	-0.14	0.26	-0.61		-0.42	-0.46	-0.07	-0.33	0.12	-0.19	-0.47	-0.35	-0.17	-0.55	-0.49	0.03	-0.45	-0.5	-0.93	0.0	-0.15	-0.07	-0.41
Net Receivables	0.91	0.67	0.77	-0.42		0.97	0.59	0.97	-0.2	0.69	0.94	0.86	0.95	0.96	0.96	0.59	0.83	0.96	0.54	-0.6	0.86	0.47	0.91
Total Liab	0.93	0.67	0.73	-0.46	0.97		0.67	0.95	-0.22	0.77	0.96	0.84	0.94	0.97	1.0	0.59	0.86	0.99	0.56	-0.59	0.89	0.57	0.94
Total Current Assets	0.81	0.81	-0.01	-0.07	0.59	0.67		0.63	0.15	0.59	0.78	0.52	0.65	0.59	0.69	0.65	0.5	0.71	0.18	-0.47	0.82	0.98	0.79
Accounts Payable	0.92	0.72	0.71	-0.33	0.97	0.95	0.63		-0.2	0.79	0.91	0.84	0.95	0.92	0.94	0.69	0.83	0.92	0.46	-0.65	0.87	0.5	0.89
Short Term Debt	-0.1	0.03	-0.42	0.12	-0.2	-0.22	0.15	-0.2		-0.07	-0.07	-0.4	-0.19	-0.22	-0.21	0.09	-0.29	-0.22	-0.17	0.61	0.0	0.22	-0.04
Intangible Assets	0.75	0.6	0.49	-0.19	0.69	0.77	0.59	0.79	-0.07		0.69	0.62	0.72	0.68	0.77	0.74	0.62	0.72	0.3	-0.48	0.72	0.5	0.68
Common Stock	0.93	0.72	0.59	-0.47	0.94	0.96	0.78	0.91	-0.07	0.69		0.77	0.91	0.96	0.97	0.63	0.82	0.97	0.55	-0.5	0.93	0.7	0.99
Property Plant Equipment	0.76	0.53	0.67	-0.35	0.86	0.84	0.52	0.84	-0.4	0.62	0.77		0.79	0.81	0.84	0.52	0.75	0.84	0.52	-0.81	0.64	0.39	0.71
Good Will	0.97	0.84	0.64	-0.17	0.95	0.94	0.65	0.95	-0.19	0.72	0.91	0.79		0.91	0.92	0.67	0.8	0.91	0.3	-0.59	0.94	0.53	0.91
Current Deferred Revenue	0.87	0.6	0.76	-0.55	0.96	0.97	0.59	0.92	-0.22	0.68	0.96	0.81	0.91		0.97	0.58	0.85	0.96	0.62	-0.49	0.86	0.5	0.94
Long Term Debt	0.92	0.66	0.72	-0.49	0.96	1.0	0.69	0.94	-0.21	0.77	0.97	0.84	0.92	0.97		0.59	0.84	1.0	0.59	-0.57	0.89	0.59	0.94
Net Tangible Assets	0.72	0.73	0.2	0.03	0.59	0.59	0.65	0.69	0.09	0.74	0.63	0.52	0.67	0.58	0.59		0.33	0.55	0.08	-0.43	0.72	0.57	0.66
Deferred Long Term Liab	0.76	0.52	0.68	-0.45	0.83	0.86	0.5	0.83	-0.29	0.62	0.82	0.75	0.8	0.85	0.84	0.33		0.84	0.55	-0.52	0.72	0.4	0.78
Long Term Debt Total	0.91	0.65	0.7	-0.5	0.96	0.99	0.71	0.92	-0.22	0.72	0.97	0.84	0.91	0.96	1.0	0.55	0.84		0.6	-0.58	0.88	0.61	0.95
Capital Surpluse	0.27	-0.09	0.65	-0.93	0.54	0.56	0.18	0.46	-0.17	0.3	0.55	0.52	0.3	0.62	0.59	0.08	0.55	0.6		-0.21	0.23	0.12	0.52
Short Long Term Debt	-0.6	-0.52	-0.36	0.0	-0.6	-0.59	-0.47	-0.65	0.61	-0.48	-0.5	-0.81	-0.59	-0.49	-0.57	-0.43	-0.52	-0.58	-0.21		-0.45	-0.35	-0.46
Net Invested Capital	0.98	0.89	0.42	-0.15	0.86	0.89	0.82	0.87	0.0	0.72	0.93	0.64	0.94	0.86	0.89	0.72	0.72	0.88	0.23	-0.45		0.75	0.94
Net Working Capital	0.71	0.72	-0.13	-0.07	0.47	0.57	0.98	0.5	0.22	0.5	0.7	0.39	0.53	0.5	0.59	0.57	0.4	0.61	0.12	-0.35	0.75		0.71
Capital Stock	0.94	0.77	0.54	-0.41	0.91	0.94	0.79	0.89	-0.04	0.68	0.99	0.71	0.91	0.94	0.94	0.66	0.78	0.95	0.52	-0.46	0.94	0.71

Click cells to compare fundamentals

About Mesa Laboratories Financial Statements

Mesa Laboratories stakeholders use historical fundamental indicators, such as Mesa Laboratories' Operating Income, to determine how well the company is positioned to perform in the future. Although Mesa Laboratories investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mesa Laboratories' assets and liabilities are reflected in the revenues and expenses on Mesa Laboratories' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mesa Laboratories. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	-272.1 M	-258.5 M
Non Operating Income Net Other	954.9 K	1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

When determining whether Mesa Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesa Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesa Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesa Laboratories Stock:

How To Invest In Mesa

Details

Is Mesa Stock a good investment?

Details

What is Mesa Laboratories' Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Mesa Laboratories Correlation against competitors.

For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.

You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. If investors know Mesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesa Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

3.875

Dividend Share

0.64

Earnings Share

(45.62)

Revenue Per Share

42.3

Quarterly Revenue Growth

0.088

The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mesa Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesa Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesa Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mesa Operating Income from 2010 to 2024

Latest Mesa Laboratories' Operating Income Growth Pattern

Mesa Operating Income Regression Statistics

Mesa Operating Income History

Other Fundumenentals of Mesa Laboratories

Mesa Laboratories Operating Income component correlations

About Mesa Laboratories Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY